CSIR Central

Discovery of novel antileishmanial agents in an attempt to synthesize aplysinopsin pentamidine hybrid molecule

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Porwal, Sharad
Chauhan, Shikha
Chauhan, P M S
Shakya, Nishi
Verma, Aditya
Gupta, Suman
 
Date 2010-09-04T06:34:36Z
2010-09-04T06:34:36Z
2009
 
Identifier J Med Chem. 2009, 52(19), 5793-802.
http://hdl.handle.net/123456789/580
 
Description In an attempt to synthesize pentamidine-aplysinopsin hybrid molecule 25, a lead molecule 8 (containing Z-configured aplysinopsin moiety) was identified for antileishmanial activity. Optimization of lead 8 provided 24 (containing E-configured aplysinopsin) possessing 10 times more activity and 401-fold less toxicity than the drug pentamidine in cell based assays. Synthesis of 24 was possible, surprisingly, because of two innate reactivities of indole-3-carbaldehyde which provided it in diastereoand regio-selectively pure form without recourse to the long reaction pathway.
 
Format 205977 bytes
application/pdf
 
Language en
 
Subject pentamidine aplysinopsin
indole-3-carbaldehyde
Leishmaniasis
cutaneous leishmaniasis
mucocutaneous leishmaniasis
protozoan Leishmania
 
Title Discovery of novel antileishmanial agents in an attempt to synthesize aplysinopsin pentamidine hybrid molecule
 
Type Article